PharmaShots Weekly Snapshots (September 04–08, 2023)
September 9, 2023
Alnylam Reports P-II Study (KARDIA-1) Results of Zilebesiran for Hypertension in Patients at High Cardiovascular Risk
September 7, 2023
Alnylam Collaborated with Roche to Co-Develop and Co-Commercialize Zilebesiran for Hypertension in Patients with High Cardiovascul...
July 24, 2023
Alnylam Reports Updated Interim Results from the P-I Study of ALN-APP for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
July 17, 2023
Alnylam Presents 18-Month P-III Study (APOLLO-B) Results of Patisiran for ATTR Amyloidosis with Cardiomyopathy at HFA 2023
May 22, 2023
Alnylam Expands its Collaboration with Medison Pharma to Commercialize RNAi Therapies
March 10, 2023
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.